Filed Pursuant to Rule 424(b)(3)
Registration No. 333-284606
PROSPECTUS SUPPLEMENT
(to Prospectus dated December 22, 2025)
266,666 American Depositary Shares representing
133,333,000
Ordinary Shares
Kazia Therapeutics Limited
This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated December 22, 2025 (the “Prospectus”), which forms a part of our Registration Statement on Form... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 28, 2026
Kiniksa Pharmaceuticals International, plc
(Exact name of Registrant as Specified in Its Charter)
England and Wales
001-730430
98-1795578
(State or other jurisdiction ofincorporation... (continue reading...)
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-290598
PROSPECTUS SUPPLEMENT
(to Prospectus dated December 23, 2025)
232,956 American Depositary Shares representing
116,478,000
Ordinary Shares
Kazia Therapeutics Limited
This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated December 23, 2025 (the “Prospectus”), which forms a part of our Registration Statement on Form... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B3 KAZIA THERAPEUTICS LTD
-
Form 8-K CONAGRA BRANDS INC. For: Jul 24
-
Form 424B3 KAZIA THERAPEUTICS LTD
-
Form 8-K BOEING CO For: Jul 28
-
Form 6-K KAZIA THERAPEUTICS LTD For: Jul 28
-
Form 10-Q Orbit Innovations Group For: Jun 30
-
Form 424B4 Catalyst Acquisition
-
Form 6-K Amber International Hold For: Jul 28
-
Form MA-I GOLDMAN SACHS & CO. LLC
-
Form MA-I/A D.A. DAVIDSON & CO.
-
Form MA-I/A D.A. DAVIDSON & CO.
-
Form 6-K Galmed Pharmaceuticals For: Jul 28
-
Form 8-K Grace Therapeutics, Inc. For: Jul 28
-
Form 8-K REPLIGEN CORP For: Jul 28
-
Form D Vitalbridge Fund III,
-
Form 8-K S&P Global Inc. For: Jul 28
-
Form 10-Q Core Scientific, Inc./tx For: Jun 30
-
Form 6-K Lifezone Metals Ltd For: Jul 28
-
Form 8-K Xylem Inc. For: Jul 28
-
Form 8-K Core Scientific, Inc./tx For: Jul 28
-
Form 8-K SHERWIN WILLIAMS CO For: Jul 28
-
Form 8-K AMERICAN TOWER CORP /MA/ For: Jul 28
-
Form 8-K Alkermes plc. For: Jul 28
-
Form 13F-HR OP Asset Management Ltd For: Jun 30
-
Form 6-K DoubleDown Interactive For: Jul 28
-
Form 6-K RedHill Biopharma Ltd. For: Jul 28
-
Form 8-K Altimmune, Inc. For: Jul 28
-
Form 8-K ASBURY AUTOMOTIVE GROUP For: Jul 28
-
Form 8-K JETBLUE AIRWAYS CORP For: Jul 28
-
Form 10-Q JETBLUE AIRWAYS CORP For: Jun 30
-
Form 8-K IQVIA HOLDINGS INC. For: Jul 28
-
Form 8-K CORNING INC /NY For: Jul 28
-
Form 8-K PayPal Holdings, Inc. For: Jul 28
-
Form 8-K INCYTE CORP For: Jul 28
-
Form 13F-HR Wesleyan Assurance Socie For: Jun 30
-
Form 6-K VersaBank For: Jul 28
-
Form 8-K ConnectOne Bancorp, Inc. For: Jul 28
-
Form 10-Q ARMSTRONG WORLD INDUSTRI For: Jun 30
-
Form 8-K Core Scientific, Inc./tx For: Jul 27
-
Form 8-K REDWOOD TRUST INC For: Jul 28
-
Form 8-K HORMEL FOODS CORP /DE/ For: Jul 27
-
Form 6-K OKYO Pharma Ltd For: Jul 28
-
Form 6-K SNDL Inc. For: Jul 28
-
Form 8-K Invesco Ltd. For: Jul 28
-
Form 8-K CARRIER GLOBAL Corp For: Jul 28
-
Form 8-K COCA COLA CO For: Jul 28
-
Form 8-K RLI CORP For: Jul 23
-
Form 6-K Vista Energy, S.A.B. de For: Jul 28
-
Form 8-K PENTAIR plc For: Jul 28
-
Form MA/A STIFEL, NICOLAUS & COMPA

